The Investor Presentation does confirm my suspicions above....
"Acquisition expected to add immediate additional revenue to our top line.
Increased margins will be achieved by selling fully priced products direct to customers.
Greater revenue per product sold will assist Osteopore accelerate our plan to become cash flow positive and profitable.
Significant opportunity to scale direct sales."
The Investor Presentation does confirm my suspicions...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
